GB895430A - Tryptamine derivatives and acid addition salts thereof - Google Patents
Tryptamine derivatives and acid addition salts thereofInfo
- Publication number
- GB895430A GB895430A GB11367/59A GB1136759A GB895430A GB 895430 A GB895430 A GB 895430A GB 11367/59 A GB11367/59 A GB 11367/59A GB 1136759 A GB1136759 A GB 1136759A GB 895430 A GB895430 A GB 895430A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkyl
- monocarbocyclic
- reacting
- prepared
- monocarbocyclic aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
The invention comprises tryptamines of the formula <FORM:0895430/IV (b)/1> or acid addition salts thereof wherein Ar represents a monocarbocyclic aryl group, preferably phenyl or phenyl substituted by one or more of the following atoms or groups: halogen, C1-4, alkyl, C1-4 alkoxy, C1-4 alkylmercapto, nitro hydroxy, C1-4 acyloxy or methylenedioxy, R1 is a hydrogen atom or a C1-4 alkyl or a monocarbocyclic aryl group as defined above and R is a C1-4 alkyl group, and the preparation thereof by reacting a 1-ArCH2-2-R1-5-RS-3-phthalimidoethylindole with hydrazine hydrate. 1-ArCH2-2-R1-5RS-3- Phthalimido - ethylindoles are prepared by reacting a monocarbocyclic aryl aldehyde with a 4-alkylmercaptoaniline to give a Schiff base, which is reduced to N - monocarbocyclic arylmethyl - 4 - alkylmercaptoaniline, the amine is converted into the nitrosoamine which in turn is reduced to the N - monocarbocyclic arylmethyl - 4 - alkyl - mercapto - phenylhydrazine and the last named compound is reacted with g -phthalimidobutyraldehyde or 3-phthalimidopropyl ketones. The hydrazines may also be prepared by reacting a 4 - alkylmercaptophenyl - hydrazine with a monocarbocyclic arylmethyl halide and an alkali metal amide in liquid ammonia and in the presence of a condensation catalyst such as ferric salts, iron or ferric oxide. g -Phthalimidobutyraldehyde is prepared by reducing g -phthalinidobutyronitrile with stannous chloride and hydrolysing the stannic aldimonium chloride formed. 3-Phthalimidopropyl alkyl and monocarbocyclic aryl ketones are prepared by reacting potassium phthalimide with a 3-chloropropyl alkyl ketone and by reacting g -phthalimido butyroyl chloride with a monocarbocyclic aryl hydrocarbon respectively.ALSO:Hypertensive compositions comprise tryptamines of the formula <FORM:0895430/VI/1> or addition salts thereof with inorganic or organic acids, wherein Ar is a monocarbocyclic aryl group (including phenyl optionally substituted by the following atoms or groups: halogen, C1-4-alkyl, C1-4-alkoxy, C1-4-alkyl-mercapto, nitro, hydroxy, C1-4 acyloxy, methylenedioxy), R is a C1-4-alkyl group and R1 is a hydrogen atom or a C1-4-alkyl or a monocarbocyclic aryl group as defined above, optionally in combination with other hypertensive agents, e.g. reserpine, in forms suitable for enteral or parenteral administration (e.g. tablets, capsules or sterile solutions).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US895430XA | 1958-04-07 | 1958-04-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB895430A true GB895430A (en) | 1962-05-02 |
Family
ID=22218233
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB11367/59A Expired GB895430A (en) | 1958-04-07 | 1959-04-03 | Tryptamine derivatives and acid addition salts thereof |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB895430A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0147107A1 (en) * | 1983-12-06 | 1985-07-03 | Glaxo Group Limited | Indole derivates |
WO2004041781A1 (en) * | 2002-11-07 | 2004-05-21 | Suven Life Sciences Limited | Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones |
-
1959
- 1959-04-03 GB GB11367/59A patent/GB895430A/en not_active Expired
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0147107A1 (en) * | 1983-12-06 | 1985-07-03 | Glaxo Group Limited | Indole derivates |
US4894387A (en) * | 1983-12-06 | 1990-01-16 | Glaxo Group Limited | 5-Substituted-3-aminoalkyl indole derivatives |
WO2004041781A1 (en) * | 2002-11-07 | 2004-05-21 | Suven Life Sciences Limited | Preparation of 3-aminoalkyl-substituted indole derivatives from phenylhydrazines and aminoketones |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES320295A1 (en) | Procedure for the preparation of new derivatives of indol. (Machine-translation by Google Translate, not legally binding) | |
GB753919A (en) | Improvements relating to derivatives of 2-aryl indoles and of 2-aryl indolines, and their use | |
GB895430A (en) | Tryptamine derivatives and acid addition salts thereof | |
GB1008645A (en) | Dibenzocycloheptane derivatives | |
GB974894A (en) | Process for the production of amine compounds | |
GB1068083A (en) | í¸-1,2,4-triazolone-(5) derivatives | |
GB1070139A (en) | Novel imidazothiazole derivatives and a process for preparation thereof | |
GB959993A (en) | Camphor derivatives | |
GB745495A (en) | Improvements in or relating to 4-substituted amino-5-hydroxy-benz(cd)-indoles and their acid addition salts and process of preparing the same | |
GB1447521A (en) | Naphthalimide-4,5-dicarboxylic acids | |
GB843440A (en) | Novel heterocyclic hydrazine derivatives and a process for the manufacture of same | |
GB991937A (en) | Indoline derivatives and process for preparing them | |
GB969266A (en) | Tryptamine derivatives | |
GB759981A (en) | Process for the manufacture of xanthine derivatives | |
GB921520A (en) | 4-fluoro and 4-bromo-3-sulphamylbenzanilides | |
GB794043A (en) | New quinoline derivatives | |
GB936919A (en) | Pharmaceutical compositions comprising homochlorcyclizine | |
GB729331A (en) | Improvements in or relating to thiazole derivatives | |
GB888418A (en) | Improvements in or relating to reserpine and its derivatives | |
GB674807A (en) | Compounds of phenyl ethyl barbituric acid with bases and the manufacture thereof | |
GB1036419A (en) | A process for the manufacture of isoquinoline derivatives | |
GB1100205A (en) | Improvements in or relating to new substituted oxindoles and the manufacture thereof | |
GB899207A (en) | Bis-xanthine compounds | |
GB1077974A (en) | Quinoline compounds and a process for their production | |
GB971042A (en) | New benzotriazole derivatives |